[Single dose of 24 Gy or 3-fraction SBRT regimen in the treatment of oligometastatic cancer? : A phase III multi-center trial]. - Hemmatazad H; Mathier E; Aebersold DM; Shelan M (Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2021)